Provided by Tiger Fintech (Singapore) Pte. Ltd.

Recursion Pharmaceuticals, Inc.

5.41
-0.0850-1.55%
Volume:39.57M
Turnover:220.81M
Market Cap:2.20B
PE:-2.97
High:5.84
Open:5.84
Low:5.37
Close:5.49
Loading ...
Feb 23, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 21, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 15, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 14, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 12, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 08, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 07, 2024

Major Issues Report

Form 8-K - Current report
Feb 07, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 31, 2024

Major Issues Report

Form 8-K - Current report
Jan 29, 2024

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Jan 26, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 24, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 18, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 17, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 16, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 10, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 10, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 10, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 08, 2024

Major Issues Report

Form 8-K - Current report